Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 08, 2024 17:30 ET | Source: PMI

Remicade Biosimilars Market Size & Share to Exceed USD 34.4 Billion by 2034, at CAGR of 9.30% - By PMI

Covina, Feb. 08, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the Remicade Biosimilars Market size was valued at about USD 15.3 Billion in 2024 and expected to grow at CAGR of...
February 08, 2024 15:30 ET | Source: PMI

Monoclonal Antibody Diagnostic Reagents Market Size & Share to Exceed USD 27.2 Billion by 2034, at CAGR of 12.30% – By PMI

Covina, Feb. 08, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the Monoclonal Antibody Diagnostic Reagents Market size was valued at about USD 8.5 Billion in 2024 and expected to...
February 05, 2024 08:00 ET | Source: Rani Therapeutics, LLC

Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111)

- RT-111 achieved high bioavailability in humans - - RT-111 was well-tolerated, with no serious adverse events - - Celltrion has right of first negotiation to acquire worldwide rights to RT-111...
June 05, 2023 08:00 ET | Source: Rani Therapeutics, LLC

Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105

SAN JOSE, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
March 16, 2023 16:05 ET | Source: Rani Therapeutics, LLC

Rani Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates

SAN JOSE, Calif., March 16, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...